MyFinsight
Home
Blog
About
new-logo-horizontal_1b0dc79e-svg
HEALTHPEAK PROPERTIES, INC. (DOC)
new-logo-horizontal_1b0dc79e-svg
HEALTHPEAK PROPERTIES, INC. (DOC)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$452,776K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Borrowings under bank line of cr...
Proceeds from janus living publi...
Proceeds from sales/principal re...
Others
Negative Cash Flow Breakdown
Repayments under bank line of cr...
Dividends paid on common stock
Development, redevelopment, and ...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income (loss)
63,241
199,656
121,792
-109,848
Depreciation and amortization of real estate, in-place lease, and other intangibles
283,390
289,734
262,086
796,779
Stock-based compensation amortization expense
4,806
4,502
4,000
4,045
Merger-related post-combination stock compensation expense
-
-
0
0
Stock-based compensation issued as part of initial public offering of janus living, inc
0
4,872
-
-
Amortization of deferred financing costs and debt discounts (premiums)
8,901
8,363
8,199
7,981
Straight-line rents
12,183
10,905
8,354
14,282
Amortization of above (below) market lease intangibles
-6,308
-6,597
-36,747
-
Amortization of non-refundable entrance fees and above (below) market lease intangibles
-
-
-
-32,261
Amortization of non-refundable entrance fees
-27,807
-27,203
-98,912
-
Equity loss (income) from unconsolidated joint ventures
2,509
4,265
2,707
-176,291
Distributions of earnings from unconsolidated joint ventures
654
251
256
7,141
Deferred income tax expense (benefit)
-2,011
-1,086
3,976
-2,199
Impairments and loan loss reserves (recoveries), net
-1,479
-2,275
-776
-54
Loss (gain) on debt extinguishments
0
-403
-
-
Loss (gain) on sales of real estate, net
9,988
50,669
56,352
11,500
Loss (gain) upon change of control, net
226
138,117
0
0
Casualty-related loss (recoveries), net
5,507
190
9,204
1,483
Other non-cash items
10,977
2,739
2,506
2,612
Decrease (increase) in accounts receivable and other assets
-26,241
-890
26,023
21,127
Increase (decrease) in accounts payable, accrued liabilities, and other liabilities
10,856
-40,706
-112,156
52,552
Increase (decrease) in deferred revenue
42,006
36,962
147,297
-
Net cash provided by (used in) operating activities
361,100
260,881
294,084
314,961
Acquisitions of real estate
114,489
427,849
442,823
6,347
Joint venture buyout, net
4,454
291,354
-
-
Development, redevelopment, and other major improvements of real estate
157,026
142,132
216,569
222,715
Leasing costs, tenant improvements, and recurring capital expenditures
42,105
23,956
57,826
27,261
Proceeds from sales of real estate, net
56,601
90,359
306,885
25,750
Proceeds from the callan ridge jv transaction, net
-
-
-
0
Proceeds from the bx jv i and ii transaction, net
0
162,801
0
-
Investments in unconsolidated joint ventures
761
1,171
10,444
22,422
Distributions in excess of earnings from unconsolidated joint ventures
7,032
8,873
5,758
7,197
Proceeds from insurance recovery
7,131
6,838
7,829
10,538
Proceeds from sales/principal repayments on loans receivable and other
398,799
5,040
22,368
58,640
Investments in loans receivable and other
18,097
26,056
20,798
11,460
Cash paid in connection with the merger, net
-
-
0
0
Net cash provided by (used in) investing activities
132,631
-638,607
-405,620
-188,080
Borrowings under bank line of credit and commercial paper
7,854,200
5,887,650
2,685,420
2,702,000
Repayments under bank line of credit and commercial paper
8,109,615
5,215,091
1,974,695
3,108,875
Issuances and borrowings of term loans, senior unsecured notes, and mortgage debt
0
0
0
492,765
Repayments and repurchases of term loans, senior unsecured notes, and mortgage debt
142,321
102,231
940
916
Payments for debt extinguishment and deferred financing costs
1,063
3,738
126
1,133
Issuance of common stock, net of offering costs
636
97
842
133
Repurchase of common stock
100,187
1,374
87
17
Dividends paid on common stock
210,256
211,994
211,861
211,874
Distributions to and redemption of noncontrolling interests
22,387
141,749
9,047
9,665
Proceeds from janus living public offerings, net of underwriting fees
691,198
901,326
0
7,154
Contributions from and issuance of noncontrolling interests
760
-
-
-
Noncontrolling interest issuance costs
1,920
6,963
-
-
Net cash provided by (used in) financing activities
-40,955
1,105,933
489,506
-130,428
Net increase (decrease) in cash, cash equivalents, and restricted cash
452,776
728,207
377,970
-3,547
Cash, cash equivalents, and restricted cash, beginning of period
1,265,909
537,702
138,606
138,606
Cash, cash equivalents, and restricted cash, end of period
1,718,685
1,265,909
537,702
159,732
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Depreciation and
amortization of real estate,...
$283,390K
(6.57%↑ Y/Y)
Net income (loss)
$63,241K
(62.08%↑ Y/Y)
Increase (decrease) in
deferred revenue
$42,006K
Proceeds from
sales/principal repayments on...
$398,799K
(12576.38%↑ Y/Y)
Decrease (increase) in
accounts receivable and...
-$26,241K
(-10.86%↓ Y/Y)
Increase (decrease) in
accounts payable,...
$10,856K
(-81.29%↓ Y/Y)
Amortization of deferred
financing costs and debt...
$8,901K
(13.03%↑ Y/Y)
Stock-based compensation
amortization expense
$4,806K
(176.52%↑ Y/Y)
Distributions of earnings from
unconsolidated joint ventures
$654K
(-75.10%↓ Y/Y)
Proceeds from sales of
real estate, net
$56,601K
(1012.22%↑ Y/Y)
Proceeds from insurance
recovery
$7,131K
(452.79%↑ Y/Y)
Distributions in excess of
earnings from...
$7,032K
(-12.86%↓ Y/Y)
Net cash provided by
(used in) operating...
$361,100K
(-0.66%↓ Y/Y)
Net cash provided by
(used in) investing...
$132,631K
(163.08%↑ Y/Y)
Canceled cashflow
$78,995K
Canceled cashflow
$336,932K
Net increase
(decrease) in cash, cash...
$452,776K
(1735.11%↑ Y/Y)
Canceled cashflow
$40,955K
Amortization of
non-refundable entrance fees
-$27,807K
Straight-line rents
$12,183K
(125.57%↑ Y/Y)
Other non-cash items
$10,977K
(329.46%↑ Y/Y)
Loss (gain) on sales
of real estate, net
$9,988K
(510.51%↑ Y/Y)
Amortization of above (below)
market lease...
-$6,308K
Casualty-related loss
(recoveries), net
$5,507K
(208.86%↑ Y/Y)
Equity loss (income)
from unconsolidated...
$2,509K
(43.62%↑ Y/Y)
Deferred income tax
expense (benefit)
-$2,011K
(-279.23%↓ Y/Y)
Impairments and loan loss
reserves (recoveries),...
-$1,479K
(-142.27%↓ Y/Y)
Loss (gain) upon
change of control, net
$226K
Development, redevelopment,
and other major...
$157,026K
(-0.82%↓ Y/Y)
Acquisitions of real estate
$114,489K
Leasing costs, tenant
improvements, and recurring...
$42,105K
(63.65%↑ Y/Y)
Investments in loans
receivable and other
$18,097K
(-18.92%↓ Y/Y)
Joint venture buyout,
net
$4,454K
Investments in
unconsolidated joint ventures
$761K
(-96.46%↓ Y/Y)
Borrowings under bank line
of credit and...
$7,854,200K
(219.97%↑ Y/Y)
Proceeds from janus
living public...
$691,198K
(11477.86%↑ Y/Y)
Contributions from and
issuance of...
$760K
(-87.27%↓ Y/Y)
Issuance of common stock,
net of offering...
$636K
(494.39%↑ Y/Y)
Net cash provided by
(used in) financing...
-$40,955K
(68.14%↑ Y/Y)
Canceled cashflow
$8,546,794K
Repayments under bank line
of credit and...
$8,109,615K
(339.87%↑ Y/Y)
Dividends paid on common
stock
$210,256K
(-0.77%↓ Y/Y)
Repayments and repurchases
of term loans,...
$142,321K
(-68.56%↓ Y/Y)
Repurchase of common stock
$100,187K
(38.99%↑ Y/Y)
Distributions to and
redemption of...
$22,387K
(149.99%↑ Y/Y)
Noncontrolling interest
issuance costs
$1,920K
Payments for debt
extinguishment and deferred...
$1,063K
Buy us a coffee